new glp 1 GLP-1 Drugs: 6 Things We've Learned About Their Effects Ro Launches Wegovy® Pill Through

doi: 10.1055/s-0029-1215269 12 FolliFGuardado MendozaR

Diabetes (Type 2) Available in NZ = Dulaglutide (Trulicity, weekly injection) or Liraglutide (Victoza, daily injection)

Outcomes Figure 1 shows the network of comparisons for the outcomes

Jen's doctor agreed she was a great candidate

Key Difference: Tirzepatide (Mounjaro/Zepbound): Dual GIP/GLP-1 agonist Semaglutide (Wegovy/Ozempic): GLP-1 agonist only Effectiveness Difference: Tirzepatide: 15-22% average body weight loss Semaglutide: 10-15% average body weight loss Semaglutide is less potent but still highly effective and significantly more affordable than brand-name tirzepatide

Manufacturer in the USA, Mexico, and Canada 1 USA: Boehringer Ingelheim Pharmaceuticals, Inc